Quality by Design in Solid-Dosage Manufacturing

September 2, 2015

In the September 2015 issue of PharmTech, Sven Stegemann is featured in an article on QbD in solid-dosage manufacturing. Read the full article here.

The quality-by-design (QbD) initiative, which focuses on building quality into a product from early on in the development process, has created a shift in the way pharmaceutical companies develop and produce drug products. With a focus on patient safety, QbD helps drug manufacturers incorporate a risk-based approach to development and production.

Topics: 
Bioavailability Enhancement